Lemaitre Vascular (LMAT) Tops Q4 EPS by 10c, Offers Guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.30, $0.10 better than the analyst estimate of $0.20. Revenue for the quarter came in at $28.4 million versus the consensus estimate of $25.91 million.

GUIDANCE:

Lemaitre Vascular sees Q1 2019 EPS of $0.18-$0.20, versus the consensus of $0.20. Lemaitre Vascular sees Q1 2019 revenue of $27.7-28.5 million, versus the consensus of $27.2 million.

Lemaitre Vascular sees FY2019 EPS of $0.82-$0.86, versus the consensus of $0.81. Lemaitre Vascular sees FY2019 revenue of $113-114 million, versus the consensus of $110.3 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M